| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
| Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
| ClinicalTrials.gov Identifier: | NCT00010621 |
Purpose
This study will determine whether selected complementary approaches to temporomandibular joint (TMJ) pain management-acupuncture are as effective as usual care.
| Condition | Intervention | Phase |
|
Temporomandibular Joint Disorders |
Procedure: Acupuncture Procedure: chiropractic therapy Procedure: bodywork therapy |
Phase II |
| MedlinePlus related topics: | Temporomandibular Joint Dysfunction |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Active Control, Parallel Assignment, Efficacy Study |
| Official Title: | Complementary Medicine Approaches to TMD Pain Management |
| Study Start Date: | September 1999 |
| Estimated Study Completion Date: | July 2004 |
Temporomandibular disorders are characterized by pain and tenderness in the muscles of mastication and/or the (TMJ), limitations of jaw opening often accompanied by deviations in mandibular path, and clicking, popping or grating TMJ sounds. This study will compare the effectiveness of the complementary therapies chiropractic therapy and bodywork therapy to the standard of care for TMJ pain. If these complementary interventions are shown to be effective, the goal is to design and implement a Phase III clinical trial to further evaluate the health consequences and cost of these therapies.
Participants will be evaluated at baseline, and 6 and 12 months post-intervention. Clinical examinations, saliva samples to assess salivary cortisol levels, and a series of questionnaires to assess pain and grade of dysfunctional pain, psychological functioning, and other physical symptoms will be used to assess outcomes. The investigators will passively monitor health care utilization within KPNW using clinical, research, and administrative databases.
Eligibility
| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contacts and Locations| United States, Oregon | |||||
| Center for Health Research | |||||
| Portland, Oregon, United States, 97227-1110 | |||||
| Principal Investigator: | Alex White | Center for Health Research (CHR), Kaiser Foundation Hospitals |
More Information
| Study ID Numbers: | P50 AT000076-01P1, P50 AT000076-01 |
| First Received: | February 2, 2001 |
| Last Updated: | August 17, 2006 |
| ClinicalTrials.gov Identifier: | NCT00010621 |
| Health Authority: | United States: Federal Government |
|
|
|
|
